TREM2 in Neurodegenerative Diseases
Abstract TREM2 variants have been identified as risk factors for Alzheimer’s disease (AD) and other neurodegenerative diseases (NDDs). Because TREM2 encodes a receptor exclusively expressed on immune cells, identification of these variants conclusively demonstrates that the immune response can play...
Main Authors: | Taylor R. Jay, Victoria E. von Saucken, Gary E. Landreth |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13024-017-0197-5 |
Similar Items
-
Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms
by: Daniel L Kober, et al.
Published: (2016-12-01) -
New insights into the role of TREM2 in Alzheimer’s disease
by: Maud Gratuze, et al.
Published: (2018-12-01) -
Inflammasomes in neuroinflammatory and neurodegenerative diseases
by: Sofie Voet, et al.
Published: (2019-06-01) -
Microglia Phenotypes Converge in Aging and Neurodegenerative Disease
by: Michael Candlish, et al.
Published: (2021-05-01) -
Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
by: Marc Suárez-Calvet, et al.
Published: (2019-01-01)